Filing Details

Accession Number:
0001209191-14-047831
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-07-17 17:08:55
Reporting Period:
2014-07-15
Filing Date:
2014-07-17
Accepted Time:
2014-07-17 17:08:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1180262 Herbalife Ltd. HLF Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1180608 Jr. Leroy Barnes 800 W. Olympic Boulevard, #406
Los Angeles CA 90015
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-07-15 8,824 $6.82 10,824 No 4 M Direct
Common Stock Disposition 2014-07-15 931 $64.65 9,893 No 4 D Direct
Common Stock Acquisiton 2014-07-15 13,064 $22.94 22,957 No 4 M Direct
Common Stock Disposition 2014-07-15 4,636 $64.65 18,321 No 4 D Direct
Common Stock Acquisiton 2014-07-15 7,503 $44.79 25,824 No 4 M Direct
Common Stock Disposition 2014-07-15 5,199 $64.65 20,625 No 4 D Direct
Common Stock Disposition 2014-07-16 18,625 $64.45 2,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 D Direct
No 4 M Direct
No 4 D Direct
No 4 M Direct
No 4 D Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Appreciation Rights Disposition 2014-07-15 8,824 $0.00 8,824 $6.82
Common Stock Stock Appreciation Rights Disposition 2014-07-15 13,064 $0.00 13,064 $22.94
Common Stock Stock Appreciation Rights Disposition 2014-07-15 7,503 $0.00 7,503 $44.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-02-27 2016-02-27 No 4 M Direct
0 2011-04-15 2017-05-07 No 4 M Direct
0 2013-04-15 2019-05-31 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2014.
  2. This transaction was executed in multiple trades at prices ranging from $64.25 to $64.84. The price reported reflects the weighted average sale price of $64.45. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.